Litcius/Paper detail

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

Christopher Melani, Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y. Song, Sara Calattini, Jun‐ichi Kawada, David A Price, Pratip K. Chattopadhyay, Mario Roederer, Andrea N. Lucas, Seth M. Steinberg, Elaine S. Jaffe, Jeffrey I. Cohen, Wyndham H. Wilson

2023The Lancet Haematology14 citationsDOI

Topics & Concepts

MedicineLymphomatoid granulomatosisVincristineInternal medicineGastroenterologyCyclophosphamideEtoposidePrednisoneSurgeryChemotherapyRituximabLymphomaLymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders research
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial | Litcius